Cannabis executive salaries: who earned what in FY24 by Steve Jones October 16, 2024October 16, 2024 While the majority of Australia’s ASX-listed cannabis firms saw revenues climb in FY24, profitability often remained […]
Company news: Folium Dispensary; Montu; Vantage Hemp Co; Cann Global; InhaleRx by Martin Lane March 4, 2024November 25, 2024
Wait goes on for Cann Global investors but firm insists deal ‘in final stages’ by Steve Jones February 28, 2024February 28, 2024
Company news: Cann Global; Cann Group; InhaleRx; AusCann; Wellnex Life; Neurotech; MGC Pharma; Stenocare by Martin Lane December 4, 2023April 30, 2024
Cann Global plots Thailand deal but trading halt goes on by Steve Jones October 24, 2023April 30, 2024
Cann Global applies to extend trading halt again as it pursues ‘major’ acquisition opportunity by Martin Lane September 18, 2023April 30, 2024
Cann Global deal falls through as wait goes on for weary shareholders by Steve Jones July 3, 2023April 30, 2024
Company news: Asterion; Ecofibre; Avecho; Epsilon Healthcare; Creso Pharma; Cann Global by Martin Lane and Steve Jones May 18, 2023April 30, 2024
Company news: Cann Global; Elixinol; Bod Science; AusCann; IvyMed Clinic; Botanix by Steve Jones and Martin Lane April 5, 2023April 30, 2024
Company news: Vitura Health; Puro; MGC Pharma; Incannex; Cann Global by Steve Jones March 8, 2023April 30, 2024